Skip to content

Psilocybin: all studies

Page 317 of 439: studies 3,161 to 3,170 of 4,389, newest first. Back to the psilocybin overview

Research

The Role of Psychedelics in Maintaining Neuroplasticity During Aging

Zenodo (CERN European Organization for Nuclear Research) February 28, 2026 Somkin Kyrylo preprint

Psychedelic compounds such as LSD and Psilocybin have historically been classified alongside illicit substances and widely regarded with skepticism. However, emerging neuroscientific evidence suggests that certain psychedelics may function as “psychoplastogens”- compounds capable of promoting structural and functional neural plasticity. Recent preclinical and early clinical studies indicate...

Psychedelic therapy and cultural humility

Translational Psychiatry February 27, 2026 Alex K. Gearin, Jennifer Docherty, Xiaofan Sun et al. 1 citation

IMPORTANCE: As psychedelic-assisted therapies gain clinical legitimacy, their cultural portability remains underexamined. While promising results have emerged from trials on existential distress in life-limiting illness, most protocols reflect Euro-American values. The expansion of these therapies calls for a pivot toward cultural humility and renewed attention to what constitutes a "good...

DOI: 10.1038/s41398-026-03913-x (opens in new tab) Full text (opens in new tab) Cultural humility Situated Cultural diversity Diversity politics +3

Psilocibina en depresión: mecanismos neurobiológicos y cambios cognitivos

Acta neurológica colombiana February 23, 2026 Ashly Verónica Arias, Mariana Carrillo Ramírez, Alejandro Hurtado López et al.

Introducción: la depresión es un trastorno psiquiátrico prevalente que impacta significativamente la calidad de vida de los individuos afectados. A pesar de los avances en los tratamientos farmacológicos, existen limitaciones tanto en su eficacia como en la duración de sus efectos terapéuticos. En este contexto, la psilocibina ha emergido como una herramienta prometedora en intervenciones...

DOI: 10.22379/anc.v42i1.1926 (opens in new tab) Limiting Test biology Vulnerability computing

Psychedelic medicine: mechanisms, evidence, and translation to practice

BMJ February 23, 2026 Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle et al. 5 citations

Over the past 15 years, psychedelic treatments have garnered substantial clinical interest, with psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) advancing to phase 3 trials for various psychiatric conditions. This state-of-the-art review examines the evidence for these treatments and their proposed mechanisms of action, and identifies key challenges in clinical translation. Psychedelic...

The Calima Mushroom Mystery: Ethnomycological possibilites among the Pre-Hispanic indigenous tribes that inhabited the Valle del Cauca territories in Colombia, South America

Mycological Spectrum February 20, 2026 Juan Camilo Rodriguez Martinez

The ritual use of neurotropic mushrooms by pre-Hispanic indigenous cultures of Colombia has attracted increasing scholarly attention in recent years.Ethnohistorical and archaeological interpretations have proposed the ceremonial use of psychoactive fungi among several indigenous groups, including the Muisca, Tayrona, Quimbaya, Zen, and related cultures.Parallel to this historical inquiry,...

DOI: 10.64993/ms.2.1.5 (opens in new tab) Full text (opens in new tab) Indigenous Mushroom Population Traditional knowledge +1

Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives

February 19, 2026 Christina Chwyl, Alissa Bazinet, Adie Wilson-Poe et al. 1 citation preprint

Background: Informed consent in psychedelic-assisted services is ethically complex, difficult to implement, and remains largely unstudied and unstandardized. Objective: The current study sought expert recommendations from experienced psychedelic facilitators on what constitutes informed consent best practices for supervised psychedelic experiences across various settings. Methods: Participants...

Updated data on Psilocybe (Hymenogastraceae, Agaricales) from the southern Brazil region and a newly proposed species

Phytotaxa February 16, 2026 Paula Santos da Silva, Virginia Ramírez-Cruz, Alexander J. Bradshaw et al.

Psilocybe is a well-known genus of fungi, commonly referred to as “magic mushrooms”, due to its production of psychoactive compounds. Research interest in this genus has experienced a resurgence due to its relevance as a potential therapy for a growing global mental health crisis. In this study, 62 specimens representing 10 species of Psilocybe from southern Brazil were examined using...

DOI: 10.11646/phytotaxa.741.3.1 (opens in new tab) Phylogenetic tree Genus Range aeronautics Phylogenetics +5

Management of obsessive-compulsive disorder in adults

BMJ February 16, 2026 Jonathan S Abramowitz, Amitai Abramovitch, Dean Mckay et al. 1 citation

Obsessive-compulsive disorder (OCD) is a chronic, often debilitating psychiatric condition characterized by intrusive thoughts and behavioral or mental rituals. Although exposure and response prevention (ERP) remains the first line treatment, many individuals do not experience full remission, highlighting the need for innovation. This review provides a comprehensive and up-to-date synthesis of...

DOI: 10.1136/bmj-2024-083443 (opens in new tab) Psychological intervention Telehealth Neuromodulation Psychological therapy +6

Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies

Pharmaceuticals February 14, 2026 Petra Dolenec, Goran Pelčić, Kristina Pilipović et al.

Glaucoma is increasingly recognized as an ischemic neurodegenerative disorder that extends beyond elevated intraocular pressure (IOP) to involve complex vascular, metabolic, and inflammatory mechanisms. Retinal ganglion cells are particularly vulnerable to ischemia-reperfusion injury, oxidative stress, and chronic neuroinflammation, leading to progressive disconnection from central visual...

UK Practitioner Psychologists' Knowledge and Harm Assessment of Psychedelics: A Cross-Sectional Study

Open Mind February 13, 2026 John Moriarty, Alan Robert Bowman, Alison Pocock preprint

Psychedelics are psychoactive substances that alter one's perception, cognition and emotion, as well as one's sense of time, place and self (Nutt, 2023, p.19). Psychedelic-assisted therapy (PAT) involves the carefully controlled administration of a psychedelic substance "alongside structured psychological support, including preparation, guidance during the psychedelic session, and post-session...